Viewing Study NCT00720356


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2025-12-25 @ 9:15 PM
Study NCT ID: NCT00720356
Status: COMPLETED
Last Update Posted: 2018-10-26
First Post: 2008-07-19
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Sponsor: Northwestern University
Organization: